$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated transmembrane ion channels expressed on the plasma membrane of many cell types, including neurons, glial cells, and immune cells. These receptors are composed of α (α2-α10) or β (β2-β4) subunits that assemble to form homomeric or heteromeric subtypes, with α7 and α4β2 nAChRs being the most abundant within the brain1,2. Dysregulation of these subtypes has been associated with Alzheimer's disease, nicotine use disorder, sleep-related hypermotor epilepsy, Parkinson's disease, and major depressive disorder, among other neurological and psychiatric conditions3,4,5,6,7,8,9,10,11,12. Rapid and reliable methods to express and quantify nAChRs are essential for understanding disease mechanisms and for developing target-selective therapeutics. However, achieving robust plasma membrane expression of these receptors is often challenging and time-consuming. The method described here enables strong surface expression of nAChRs within approximately 24 h after DNA transfection and can be combined with ligands or chaperone proteins that modulate receptor trafficking.
Several approaches exist for expressing nAChRs, including transient DNA transfection or the generation of stable cell lines that express the desired subtype. Although creating stable cell lines is useful for long-term studies involving the same receptor subtype, the process is labor-intensive and can require several months. Once established, such cell lines may exhibit variable receptor expression across passages, loss of expression over time, or selection bias for clones with suboptimal receptor function or density13. A reduction in incubation temperature from 37 °C to 30 °C, the addition of molecular chaperones such as nicotine, or extended incubation time can promote surface expression13,14,15. These limitations are particularly pronounced for heteromeric nAChRs, which require proper subunit assembly and trafficking, and for studies focusing on chaperone-assisted receptor regulation. Therefore, routine validation of receptor subtype expression across passages is necessary when working with stable nAChR-expressing cell lines.
Often, researchers are interested in nAChR subunit variants and chaperone or auxiliary protein subunits and thus need to express a variety of DNAs in quick succession to allow for rapid flexibility in their assays. Transient expression of nAChRs is advantageous in this regard because the process can be completed rapidly, allowing the researcher to study multiple receptor subtypes or experimental conditions without waiting months to generate stable cell lines. A common occurrence, even with transient expression, is that many nAChRs remain inside the cell 24 h after induction at 37 °C, requiring additional incubation periods of > 48 h16,17. For example, without the chaperone protein resistant to inhibitors of cholinesterase (RIC)-3, only ~1% of α7 nAChRs are expressed on the plasma membrane of mammalian SHE-P cells18. With co-expression of RIC-3, approximately 20% of α7 nAChRs are detected on the surface. While this represents an improvement, total receptor abundance remains low. Co-expression of α7 nAChRs with NACHO can further enhance surface expression, though still less than 40% of the total receptor population traffics to the plasma membrane19. Another approach involves incubating transfected cells at 30 °C to improve plasma membrane expression20,21. For α4β2 nAChRs, this temperature reduction yields a fivefold upregulation in surface receptor density with no corresponding increase in total subunit protein21. However, this improvement requires at least one additional day and greater use of consumables, reagents, and instrumentation.
The presented work offers a set of optimized methods to express and quantify specific nAChR subtypes within 24 h post-transfection in mammalian N2a cells, achieving approximately 83% for α7, 77% for α4, and 56% for β2 subunits localized to the plasma membrane. In the case of α7 nAChRs, plasma membrane expression can be quantified using α7-selective fluorescently labeled α-bungarotoxin (αBTX) or through recombinant fluorescent tagging. To label each subunit, the pH-sensitive fluorescent proteins pHuji and superecliptic pHluorin (SEP)22,23,24 are engineered onto the C-terminus of individual nAChR subunits25,26. pHuji and SEP are pH-sensitive variants of red and green fluorescent proteins, respectively, that fluoresce at pH 7.4 but are quenched under more acidic conditions27,28. As SEP and pHuji fluorescence is suppressed at pH < 6, any observed intracellular signal reflects fluorophores located in neutral compartments rather than on the plasma membrane. It should be noted that some organelles, such as the Golgi apparatus, have an acidic lumen; thus, fluorophores attached to the C-terminal region of nAChR subunits are not detected while subunits transit through the secretory pathway29. The difference between total fluorescence at pH 7.5 and that at pH < 6 represents the signal generated by nAChRs located on the plasma membrane. Capturing images using live-cell confocal microscopy provides high spatial resolution, enabling precise quantification of subunit localization. Additionally, performing all experiments on live cells allows each cell to serve as its own control, accounting for variability in protein expression between cells within each treatment group30. This method can be further adapted to include additional chaperone proteins, such as NACHO or others, to investigate nAChR trafficking. Additional applications include pharmacological modulation, incorporation of auxiliary subunits, and analysis of disease-associated changes in nAChR expression.